We are live on
!
Find out more
KT
Kevin Tang Portfolio holdings
AUM
$783
1-Year Est. Return
75.59%
This Fund
S&P 500
This Quarter
Est. Return
-21.88%
1 Year Est. Return
-75.59%
3 Year Est. Return
-70.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.5M
AUM Growth
–
Cap. Flow
+$2.58M
Cap. Flow
% of AUM
103.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
+$1.56M |
| 2 |
Heron Therapeutics
HRTX
|
+$1.02M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
GM
ALBM
RIA
MVPI
AV
TMC
TAM
AC
Kevin Tang's Q1 2019 Portfolio in Review
Q1 2019 is the first quarter with a 13F filing on record for Kevin Tang, which disclosed 2 positions worth $2.5M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is La Jolla Pharmaceutical Company: 240,000 shares worth $1.54M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Kevin Tang's largest Q1 2019 buy was La Jolla Pharmaceutical Company: 240,000 shares worth $1.54M.
- Kevin Tang's ten largest holdings make up 100% of its $2.5M portfolio in Q1 2019.
- Kevin Tang disclosed 2 positions in Q1 2019, its first 13F filing on record.
Based on Kevin Tang's 13F filing for Q1 2019, filed 15 May 2019.